Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A multi-disciplinary team of researchers in Oxford and Newcastle, led by Professor Rutger Ploeg from the Nuffield Department of Surgical Sciences, has been awarded a grant of £1.7 million from the Medical Research Council. The four-year grant will enable the expansion of the successful Quality in Organ Donation (QUOD) initiative, currently funded and supported by NHS Blood and Transplant.

QUOD concerns a national consortium, rolled out in 2014, to facilitate research on donor organ quality and how organs can be better utilized to increase the number of transplants in the United Kingdom. This unique national resource combines detailed clinical information from virtually all organ donors in the UK with a biobank of blood, urine, and tissue samples taken around the time of donation. Such a combination of data and samples has enabled research on the mechanisms of organ damage and repair, leading to better selection and optimisation of organs for successful transplantation.

Until now, QUOD has focused on kidney and liver donors, but the MRC grant will allow the QUOD biobank to collect samples for research from heart, lung, and pancreatic donors. Furthermore, the grant will allow QUOD to create scientific platforms including state-of-the-art pathology, genomics, proteomics, and imaging techniques to develop online searchable atlases, representing a spectrum of normal, stressed, and chronically diseased organs.

The science and technology platforms involve multidisciplinary teams of scientists, clinicians, and other health care professionals, including Professors James Shaw, John Dark, and Dina Tiniakos in Newcastle, and Professors Benedikt Kessler, Anna Gloyn, and Paul Johnson in Oxford.

This connection of high-quality clinical information, easily monitored samples, and newly identified biomarkers does not currently exist. The QUOD expansion will thus create invaluable tools for the scientific and clinical community. It will facilitate new understanding of the causes of organ stress, leading to new treatments to maximise transplant success but may also help to prevent or even reverse chronic diseases without the need for transplantation.

Ultimately, the QUOD expansion aims to further the overall QUOD mission: saving lives and cutting health care costs by increasing the pool of transplantable organs, thereby addressing the growing gap between supply and demand in organ transplantation.

Present and future QUOD resources benefit researchers in academia and industry across the country. For more information on QUOD, including how to access samples for research, please visit the QUOD website.

 

Logos

Similar stories

New reporting guidelines to bridge the gap from development to implementation in clinical artificial intelligence

Innovation Research

In a correspondence to Nature Medicine, a team of Oxford-led academics describe upcoming new guidelines to improve the reporting of early clinical stage (or first-with-human) evaluation of decision support systems driven by artificial intelligence.

Cochrane ENT awarded NIHR funding for COVID-19 project

Awards and appointments Coronavirus COVID-19 Research

Cochrane ENT at the Nuffield Department of Surgical Sciences has been awarded funding by the National Institute for Health Research (NIHR) to complete a suite of living systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell after COVID-19 infection.

First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy

Coronavirus COVID-19 Publication Research

Today University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.

Applications for Oxford-Wolfson-Marriott-Patel Scholarship now open

Awards and appointments Department Research

The Nuffield Department of Surgical Sciences (NDS) are pleased to confirm that one scholarship will be available for Home (UK) and Republic of Ireland (ROI) candidates for the DPhil in Surgical Sciences, starting in Michaelmas Term 2021.

Oxford University breakthrough on global COVID-19 vaccine

Coronavirus COVID-19 Research

The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.

Transplant kidney survival rate improves with new method of transportation

Publication Research

New research by the Consortium for Organ Preservation in Europe (COPE) has found that a new method to transport donor kidneys, which uses a combination of cold perfusion with oxygen, can significantly improve transplant results, with less graft failure, better function and lower rejection of the kidney when compared to cold perfusion alone. For patients who need a kidney transplant this is a big step forward. The study, carried out in Belgium, The Netherlands and the UK, was published today in The Lancet.